Award
National Institute of Neurological Disorders and Stroke 5R41NS130812-02
Next-generation nanomedicine for acute ischemic stroke
Recipient
Not Specified
Award Amount
$351,461.00
Ceiling
$351,461.00
Awarded
September 12, 2025
Identifier
5R41NS130812-02
NIH awarded a SBIR/STTR grant to develop and optimize nanocarriers for acute ischemic stroke treatment, focusing on minimizing immune activation and testing efficacy in mouse models, with funding of $351,461 for FY2025.
Description
This is a NIH SBIR/STTR grant project focused on developing nanocarriers for stroke treatment. The project aims to optimize nanocarriers to minimize immune activation and test efficacy in mouse models. The project is funded for FY2025 with a total award amount of $351,461.